| Michael R Donnally, MD | |
|
500 London Ave, Marysville, OH 43040-5512 | |
| (937) 642-5490 | |
| Not Available |
| Full Name | Michael R Donnally |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 20 Years |
| Location | 500 London Ave, Marysville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245359520 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35089324 (Ohio) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 35089324 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital | Marysville, OH | Hospital |
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Internal Medicine Llc | 5496651408 | 984 |
News Archive
After a decade of work, a team led by Hôpital Maisonneuve-Rosemont researcher and Université de Montréal associate professor Dr. Gilbert Bernier has shed promising light on the origin of the most common and prevalent form of Alzheimer's disease, hoping to someday help mitigate or even reverse the progress of the disease.
LivaNova, PLC (the "Company"), a global medical technology company and a leader in the treatment of cardiovascular diseases, announced the first U.S. implantation of the Perceval valve, the sutureless biological aortic replacement valve.
Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have found that just two small changes in the virus that caused the 1918 Spanish flu pandemic stopped it from jumping between mammals in the laboratory.
Anecdotal evidence of food allergies abounds, but just how common are these allergies and intolerances? In a new study, investigators from Brigham and Women's Hospital combed through medical records from more than 2.7 million patients, identifying more than 97,000 with one or more documented food allergy or intolerance.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 4 days ago
| Entity Name | Osu Internal Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
After a decade of work, a team led by Hôpital Maisonneuve-Rosemont researcher and Université de Montréal associate professor Dr. Gilbert Bernier has shed promising light on the origin of the most common and prevalent form of Alzheimer's disease, hoping to someday help mitigate or even reverse the progress of the disease.
LivaNova, PLC (the "Company"), a global medical technology company and a leader in the treatment of cardiovascular diseases, announced the first U.S. implantation of the Perceval valve, the sutureless biological aortic replacement valve.
Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have found that just two small changes in the virus that caused the 1918 Spanish flu pandemic stopped it from jumping between mammals in the laboratory.
Anecdotal evidence of food allergies abounds, but just how common are these allergies and intolerances? In a new study, investigators from Brigham and Women's Hospital combed through medical records from more than 2.7 million patients, identifying more than 97,000 with one or more documented food allergy or intolerance.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael R Donnally, MD 500 London Ave, Marysville, OH 43040-5512 Ph: (937) 642-5490 | Michael R Donnally, MD 500 London Ave, Marysville, OH 43040-5512 Ph: (937) 642-5490 |
News Archive
After a decade of work, a team led by Hôpital Maisonneuve-Rosemont researcher and Université de Montréal associate professor Dr. Gilbert Bernier has shed promising light on the origin of the most common and prevalent form of Alzheimer's disease, hoping to someday help mitigate or even reverse the progress of the disease.
LivaNova, PLC (the "Company"), a global medical technology company and a leader in the treatment of cardiovascular diseases, announced the first U.S. implantation of the Perceval valve, the sutureless biological aortic replacement valve.
Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have found that just two small changes in the virus that caused the 1918 Spanish flu pandemic stopped it from jumping between mammals in the laboratory.
Anecdotal evidence of food allergies abounds, but just how common are these allergies and intolerances? In a new study, investigators from Brigham and Women's Hospital combed through medical records from more than 2.7 million patients, identifying more than 97,000 with one or more documented food allergy or intolerance.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 4 days ago
Dr. Abha R. Gupta, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 London Ave, Marysville, OH 43040 Phone: 937-578-2275 Fax: 937-578-4677 | |
Colleen A Fink, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 843 Colemans Crossing Blvd, Marysville, OH 43040 Phone: 937-578-4325 | |
Dr. Ritu Madan, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 London Ave, Marysville, OH 43040 Phone: 937-578-2020 | |
Justin K Krueger, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 140 Colemans Crossing Boulevard, Suite 210, Marysville, OH 43040 Phone: 937-644-1441 Fax: 937-642-7760 | |
Dr. Prasanna K Muniyappa, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 660 London Ave, Suite A, Marysville, OH 43040 Phone: 937-642-1550 Fax: 937-578-2821 | |
Kathryn Z Gathof, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1044 Columbus Avenue, Marysville, OH 43040 Phone: 937-644-1441 Fax: 937-642-7760 |